Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting

Background : The factors associated with non-adherence to obesity treatment using liraglutide 3.0 mg in a real-world setting remain elusive. Methods : We performed a secondary data analysis of 769 participants treated with liraglutide 3.0 mg from December 2017 to June 2020 at nine Korean hospitals....

Full description

Bibliographic Details
Main Authors: Hae-Jin Ko, Jin-Wook Kim, Soo Lim
Format: Article
Language:English
Published: Korean Society for the Study of Obesity 2022-09-01
Series:Journal of Obesity & Metabolic Syndrome
Subjects:
Online Access:http://journaleditor.inforang.com/journal/view.html?doi=10.7570/jomes22029